Citation Impact
5 from Science/Nature 58 standout
Citing Papers
NAFLD and NASH: etiology, targets and emerging therapies
2024 Standout
Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease
2023 Standout
Works of Rebecca Kunder being referenced
Fibroblast growth factor receptor 1/Klothoβ agonist BFKB8488A improves lipids and liver health markers in patients with diabetes or NAFLD: A phase 1b randomized trial
2022
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial
2018
Author Peers
| Author | Molecular Biology | Surgery | RNMI | PRM | Genetics | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| Rebecca Kunder | 333 | 46 | 12 | 152 | 147 | 11 | 652 | |
| Angelo L T Ilersich | 6 | 54 | 5 | 30 | 8 | 14 | 702 | |
| S. Sankaran | 9 | 2 | 9 | 26 | 864 | |||
| Mariem Ellouze | 29 | 1 | 22 | 174 | ||||
| Hao Shi | 244 | 47 | 4 | 17 | 21 | 11 | 377 | |
| Sarai Rodríguez | 377 | 41 | 54 | 105 | 93 | 12 | 651 |
All Works
Loading papers...